Cotton fibres instead of carbon nanotubes
Similar to carbon nanotubes that are used in cycling helmets and tennis rackets, cellulose nanofibres are extremely light while being extremely tear-resistant. But their production is significantly cheaper because they can be manufactured from plant waste of cotton or banana plants. "It is only a matter of time before they prevail on the market," says Christoph Weder of the Adolphe Merkle Institute at the University of Fribourg.
In the context of the National Research Programme "Opportunities and Risks of Nanomaterials" (NRP 64), he collaborated with the team of Barbara Rothen-Rutishauser to examine whether these plant-based nanofibres are harmful to the lungs when inhaled. The investigation does not rely on animal testing; instead the group of Rothen-Rutishauser developped a complex 3D lung cell system to simulate the surface of the lungs by using various human cell cultures in the test tube.
The shorter, the better
Their results show that cellulose nanofibres are not harmful: the analysed lung cells showed no signs of acute stress or inflammation. But there were clear differences between short and long fibres: the lung cell system efficiently eliminated short fibres while longer fibres stayed on the cell surface.
"The testing only lasted two days because we cannot grow the cell cultures for longer," explains Barbara Rothen-Rutishauser. For this reason, she adds, they cannot say if the longer fibre may have a negative impact on the lungs in the long term. Tests involving carbon nanotubes have shown that lung cells lose their equilibrium when they are faced with long tubes because they try to incorporate them into the cell to no avail. "This frustrated phagocytosis can trigger an inflammatory reaction," says Rothen-Rutishauser. To avoid potential harm, she recommends that companies developing products with nanofibres use fibres that are short and pliable instead of long and rigid.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.